Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of Na V1.7

Molecular Pain

Volumn 7, Issue , 2011, Pages

  Estacion, Mark ^a,b   Han, Chongyang ^a,b   Choi, Jin Sung ^a,b,g   Hoeijmakers, Janneke G J ^c   Lauria, Giuseppe ^d   Drenth, Joost P H ^e   Gerrits, Monique M ^c   Dib Hajj, Sulayman D ^a,b   Faber, Catharina G ^c   Merkies, Ingemar S J ^c,f   Waxman, Stephen G ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Infection and Immunology   (Netherlands)

^g The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SODIUM CHANNEL NAV1.7; SCN9A PROTEIN, HUMAN; SODIUM CHANNEL;

ADULT; ARTICLE; BURNING SENSATION; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; DRUG TREATMENT FAILURE; FACE PAIN; FAMILY STUDY; FEMALE; FOOT PAIN; GENE; GENE IDENTIFICATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOME ANALYSIS; HAND; HOT FLUSH; HUMAN; JAW PAIN; MALE; MYALGIA; NERVE CELL EXCITABILITY; NEUROPATHY; PAIN; PARESTHESIA; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCALP; SCN94 GENE; SENSORY ANALYSIS; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BIOPSY; SMALL FIBER NEUROPATHY; SPINAL GANGLION; STOMACH DISCOMFORT; TRIGEMINUS GANGLION; AMINO ACID SEQUENCE; CELL STRAIN HEK293; GENETIC TRANSFECTION; GENETICS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NERVE CELL; PATCH CLAMP; SOMATOFORM DISORDER;

AMINO ACID SEQUENCE; FEMALE; GANGLIA, SPINAL; GENETIC VARIATION; HEK293 CELLS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEURONS; PATCH-CLAMP TECHNIQUES; PHENOTYPE; SODIUM CHANNELS; SOMATOFORM DISORDERS; TRANSFECTION;

EID: 82455171777     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-7-92     Document Type: Article

References (39)

1. Toledo-Aral JJ, Moss BL, He ZJ, Koszowski AG, Whisenand T, Levinson SR, Wolf JJ, Silos-Santiago I, Halegoua S, Mandel G. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci USA 1997, 94(4):1527-1532. 10.1073/pnas.94.4.1527, 19825, 9037087.
2. Rush AM, Dib-Hajj SD, Liu S, Cummins TR, Black JA, Waxman SG. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci USA 2006, 103(21):8245-8250. 10.1073/pnas.0602813103, 1472458, 16702558.
3. Sangameswaran L, Fish LM, Koch BD, Rabert DK, Delgado SG, Ilnicka M, Jakeman LB, Novakovic S, Wong K, Sze P, et al. A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J Biol Chem 1997, 272(23):14805-14809. 10.1074/jbc.272.23.14805, 9169448.
4. Persson AK, Black JA, Gasser A, Cheng X, Fischer TZ, Waxman SG. Sodium-calcium exchanger and multiple sodium channel isoforms in intra-epidermal nerve terminals. Mol Pain 2010, 6:84. 3002896, 21118538.
5. Cummins TR, Howe JR, Waxman SG. Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J Neurosci 1998, 18(23):9607-9619.
6. Waxman SG. Neurobiology: a channel sets the gain on pain. Nature 2006, 444(7121):831-832. 10.1038/444831a, 17167466.
7. Dib-Hajj SD, Cummins TR, Black JA, Waxman SG. Sodium channels in normal and pathological pain. Annu Rev Neurosci 2010, 33:325-347. 10.1146/annurev-neuro-060909-153234, 20367448.
8. Fertleman CR, Ferrie CD, Aicardi J, Bednarek NA, Eeg-Olofsson O, Elmslie FV, Griesemer DA, Goutieres F, Kirkpatrick M, Malmros IN, et al. Paroxysmal extreme pain disorder (previously familial rectal pain syndrome). Neurology 2007, 69(6):586-595. 10.1212/01.wnl.0000268065.16865.5f, 17679678.
9. Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abrahamsen B, Ostman J, Klugbauer N, Wood JN, Gardiner RM, et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006, 52(5):767-774. 10.1016/j.neuron.2006.10.006, 17145499.
10. Lacomis D. Small-fiber neuropathy. Muscle Nerve 2002, 26(2):173-188. 10.1002/mus.10181, 12210380.
11. Lauria G. Small fibre neuropathies. Curr Opin Neurol 2005, 18(5):591-597. 10.1097/01.wco.0000177330.35147.70, 16155446.
12. Stewart JD, Low PA, Fealey RD. Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve 1992, 15(6):661-665. 10.1002/mus.880150605, 1324425.
13. Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, Nolano M, Merkies IS, Polydefkis M, Smith AG, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010, 17(7):903-912. e944-909, 10.1111/j.1468-1331.2010.03023.x, 20642627.
14. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010, 33(10):2285-2293. 10.2337/dc10-1303, 2945176, 20876709.
15. Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, Broglio L, Granieri E, Lauria G. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008, 131(Pt 7):1912-1925. 2442424, 18524793.
16. Bednarik J, Vlckova-Moravcova E, Bursova S, Belobradkova J, Dusek L, Sommer C. Etiology of small-fiber neuropathy. J Peripher Nerv Syst 2009, 14(3):177-183. 10.1111/j.1529-8027.2009.00229.x, 19909481.
17. Faber CG, Hoeijmakers JG, Ahn HS, Cheng X, Han C, Choi JS, Estacion M, Lauria G, Vanhoutte EK, Gerrits MM, et al. Gain of function Na(V) 1.7 mutations in idiopathic small fiber neuropathy. Annals of neurology 2011,
18. Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, Devigili G, Smith AG, Hsieh ST, Mellgren SI, Umapathi T, et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 2010, 15(3):202-207. 10.1111/j.1529-8027.2010.00271.x, 21040142.
19. Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005, 57(4):397-409. 10.1124/pr.57.4.4, 16382098.
20. Singh NA, Pappas C, Dahle EJ, Claes LR, Pruess TH, De Jonghe P, Thompson J, Dixon M, Gurnett C, Peiffer A, et al. A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet 2009, 5(9):e1000649. 10.1371/journal.pgen.1000649, 2730533, 19763161.
21. Drenth JP, Waxman SG. Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders. J Clin Invest 2007, 117(12):3603-3609. 10.1172/JCI33297, 2096434, 18060017.
22. Estacion M, Dib-Hajj SD, Benke PJ, Te Morsche RH, Eastman EM, Macala LJ, Drenth JP, Waxman SG. NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci 2008, 28(43):11079-11088. 10.1523/JNEUROSCI.3443-08.2008, 18945915.
23. Estacion M, Choi JS, Eastman EM, Lin Z, Li Y, Tyrrell L, Yang Y, Dib-Hajj SD, Waxman SG. Can robots patch-clamp as well as humans? Characterization of a novel sodium channel mutation. J Physiol 2010, 588(Pt 11):1915-1927. 2901980, 20123784.
24. Choi JS, Dib-Hajj SD, Waxman SG. Inherited erythermalgia: limb pain from an S4 charge-neutral Na channelopathy. Neurology 2006, 67(9):1563-1567. 10.1212/01.wnl.0000231514.33603.1e, 16988069.
25. Choi JS, Cheng X, Foster E, Leffler A, Tyrrell L, Te Morsche RH, Eastman EM, Jansen HJ, Huehne K, Nau C, et al. Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia. Brain 2010, 133(Pt 6):1823-1835.
26. Estacion M, Harty TP, Choi JS, Tyrrell L, Dib-Hajj SD, Waxman SG. A sodium channel gene SCN9A polymorphism that increases nociceptor excitability. Ann Neurol 2009, 66(6):862-866. 10.1002/ana.21895, 20033988.
27. Reimann F, Cox JJ, Belfer I, Diatchenko L, Zaykin DV, McHale DP, Drenth JP, Dai F, Wheeler J, Sanders F, et al. Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci USA 2010, 107(11):5148-5153. 10.1073/pnas.0913181107, 2841869, 20212137.
28. Sabin TD. Classification of peripheral neuropathy: the long and the short of it. Muscle Nerve 1986, 9(8):711-719. 10.1002/mus.880090806, 2431310.
29. Waxman SG, Brill MH, Geschwind N, Sabin TD, Lettvin JY. Probability of conduction deficit as related to fiber length in random-distribution models of peripheral neuropathies. J Neurol Sci 1976, 29(1):39-53. 10.1016/0022-510X(76)90079-4, 181541.
30. Viader A, Golden JP, Baloh RH, Schmidt RE, Hunter DA, Milbrandt J. Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function. J Neurosci 2011, 31(28):10128-10140. 10.1523/JNEUROSCI.0884-11.2011, 21752989.
31. Baloh RH. Mitochondrial dynamics and peripheral neuropathy. Neuroscientist 2008, 14(1):12-18.
32. Bakkers M, Merkies IS, Lauria G, Devigili G, Penza P, Lombardi R, Hermans MC, van Nes SI, De Baets M, Faber CG. Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 2009, 73(14):1142-1148. 10.1212/WNL.0b013e3181bacf05, 19805731.
33. Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, Giuliani MJ, Kincaid JC, Ochoa JL, Parry GJ, Weimer LH. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003, 60(6):898-904.
34. Reulen JP, Lansbergen MD, Verstraete E, Spaans F. Comparison of thermal threshold tests to assess small nerve fiber function: limits vs. levels. Clin Neurophysiol 2003, 114(3):556-563. 10.1016/S1388-2457(02)00405-4, 12705436.
35. Yarnitsky D, Sprecher E. Thermal testing: normative data and repeatability for various test algorithms. J Neurol Sci 1994, 125(1):39-45. 10.1016/0022-510X(94)90239-9, 7964887.
36. Hoitsma E, Drent M, Verstraete E, Faber CG, Troost J, Spaans F, Reulen JP. Abnormal warm and cold sensation thresholds suggestive of small-fiber neuropathy in sarcoidosis. Clin Neurophysiol 2003, 114:2326-2333. 10.1016/S1388-2457(03)00259-1, 14652091.
37. Drenth JP, te Morsche RH, Guillet G, Taieb A, Kirby RL, Jansen JB. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. The Journal of investigative dermatology 2005, 124(6):1333-1338. 10.1111/j.0022-202X.2005.23737.x, 15955112.
38. Klugbauer N, Lacinova L, Flockerzi V, Hofmann F. Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. The EMBO journal 1995, 14(6):1084-1090. 398185, 7720699.
39. Dib-Hajj SD, Choi JS, Macala LJ, Tyrrell L, Black JA, Cummins TR, Waxman SG. Transfection of rat or mouse neurons by biolistics or electroporation. Nat Protoc 2009, 4(8):1118-1126. 10.1038/nprot.2009.90, 19617884.